NewLeaf Symbiotics

Science-based company doing cutting-edge research and product development, using a naturally occurring family of beneficial plant bacteria.

Launch date

2012

Employees

Market cap

Enterprise valuation

Olivette Missouri (HQ)

Date	Investors	Amount	Round
Jan 2013*	RockPort Capital Pangaea Ventures Open Prairie	$7.0m	Series A
Sep 2014	Palo Alto Investors RockPort Capital Pangaea Ventures Open Prairie	$17.0m	Series B
Mar 2017	N/A	$3.6m	Debt
Jul 2017	Otter Capital RockPort Capital Pangaea Ventures Monsanto The Yard Ventures S2G Ventures Lewis & Clark Ventures Alumni Ventures Open Prairie	$30.0m	Series C
Feb 2020*	Otter Capital RockPort Capital S2G Ventures Koch Agronomic Services	$20.0m	Series D
Dec 2020	Koch Industries SABIC Bayer	$2.0m Valuation: $150m	Series D
Dec 2021	N/A	$10.0m	Convertible
Dec 2023*	Otter Capital S2G Ventures Leaps by Bayer Gullspång Re:food	$45.0m	Series D
Total Funding		$131m

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by NewLeaf Symbiotics Dec 2013

Recent News about NewLeaf Symbiotics